SDGR

#2541
Schrodinger, Inc. Common Stock
11.87 USD
+3.67%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
11.85
11.92
Year Range
10.95
27.63
Daily Change
+3.67%
Monthly Change
-5.94%
6 month change
-40.11%
Year Change
-54.87%
Previous Close
11.45
Open
11.90
Bid
Ask
Low
11.85
High
11.92
Volume
171
Open full chart

Financials

Overview Statement Statistics
Quarterly Annual
  • Market Capitalization 876.3 M
  • Employee 850
  • Founded 1990
  • CEO Ramy Farid
  • Website www.schrodinger.com
  • Headquarter Delaware, United States
  • FIGI BBG000T88BN2
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-12.68
Price to sales ratio
5.13

Schrodinger Inc

Schrödinger, Inc. is an international scientific software and biotechnology company that specializes in developing computational tools and software for drug discovery and materials science. Schrödinger's software is used by pharmaceutical companies, biotech, tech, chemicals, energy, aerospace firms, and academic researchers to simulate and model the behavior of molecules at the atomic level. This accelerates the design and develops new drugs and materials more efficiently, reducing the time and cost of bringing them to market. Schrödinger's software tools include molecular dynamics simulations, free energy calculations, quantum mechanics calculations, and virtual screening tools. The company also offers consulting services and collaborates with partners in the industry to advance the field of computational chemistry and drug discovery.

News